vs

Side-by-side financial comparison of ALPHA PRO TECH LTD (APT) and Envoy Medical, Inc. (COCH). Click either name above to swap in a different company.

ALPHA PRO TECH LTD is the larger business by last-quarter revenue ($13.9M vs $75.0K, roughly 184.8× Envoy Medical, Inc.). ALPHA PRO TECH LTD runs the higher net margin — 5.0% vs -8781.3%, a 8786.4% gap on every dollar of revenue. On growth, Envoy Medical, Inc. posted the faster year-over-year revenue change (78.6% vs 0.3%). ALPHA PRO TECH LTD produced more free cash flow last quarter ($51.0K vs $-5.9M). Over the past eight quarters, Envoy Medical, Inc.'s revenue compounded faster (12.7% CAGR vs 1.4%).

Alpha Pro Tech Ltd is a leading developer, manufacturer and marketer of disposable protective apparel, face masks, and building supply products including weather-resistant barriers. It primarily serves the healthcare, industrial, and construction sectors, with core operating markets concentrated in North America.

Envoy Medical, Inc. is a medical technology firm specializing in developing and commercializing advanced implantable hearing solutions for sensorineural hearing loss patients. Its core products include fully implanted middle ear hearing devices, with primary markets across North America and Europe, serving users who gain limited benefit from conventional external hearing aids.

APT vs COCH — Head-to-Head

Bigger by revenue
APT
APT
184.8× larger
APT
$13.9M
$75.0K
COCH
Growing faster (revenue YoY)
COCH
COCH
+78.2% gap
COCH
78.6%
0.3%
APT
Higher net margin
APT
APT
8786.4% more per $
APT
5.0%
-8781.3%
COCH
More free cash flow
APT
APT
$5.9M more FCF
APT
$51.0K
$-5.9M
COCH
Faster 2-yr revenue CAGR
COCH
COCH
Annualised
COCH
12.7%
1.4%
APT

Income Statement — Q4 2025 vs Q4 2025

Metric
APT
APT
COCH
COCH
Revenue
$13.9M
$75.0K
Net Profit
$698.0K
$-6.6M
Gross Margin
37.1%
-181.3%
Operating Margin
6.9%
-8513.3%
Net Margin
5.0%
-8781.3%
Revenue YoY
0.3%
78.6%
Net Profit YoY
-17.6%
-42.6%
EPS (diluted)
$0.06
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APT
APT
COCH
COCH
Q4 25
$13.9M
$75.0K
Q3 25
$14.8M
$42.0K
Q2 25
$16.7M
$78.0K
Q1 25
$13.8M
$46.0K
Q4 24
$13.8M
$42.0K
Q3 24
$14.3M
$56.0K
Q2 24
$16.3M
$68.0K
Q1 24
$13.5M
$59.0K
Net Profit
APT
APT
COCH
COCH
Q4 25
$698.0K
$-6.6M
Q3 25
$976.0K
$-6.5M
Q2 25
$1.2M
$-5.7M
Q1 25
$613.0K
$-5.0M
Q4 24
$847.0K
$-4.6M
Q3 24
$862.0K
$-6.0M
Q2 24
$1.6M
$-3.9M
Q1 24
$576.0K
$-6.3M
Gross Margin
APT
APT
COCH
COCH
Q4 25
37.1%
-181.3%
Q3 25
39.7%
-383.3%
Q2 25
36.8%
-200.0%
Q1 25
39.0%
-391.3%
Q4 24
37.6%
-273.8%
Q3 24
38.5%
-233.9%
Q2 24
42.0%
-260.3%
Q1 24
40.2%
-159.3%
Operating Margin
APT
APT
COCH
COCH
Q4 25
6.9%
-8513.3%
Q3 25
7.4%
-13590.5%
Q2 25
8.0%
-6500.0%
Q1 25
3.3%
-11102.2%
Q4 24
4.9%
-10828.6%
Q3 24
5.2%
-8878.6%
Q2 24
10.5%
-7135.3%
Q1 24
2.4%
-8278.0%
Net Margin
APT
APT
COCH
COCH
Q4 25
5.0%
-8781.3%
Q3 25
6.6%
-15433.3%
Q2 25
7.5%
-7294.9%
Q1 25
4.4%
-10865.2%
Q4 24
6.1%
-10995.2%
Q3 24
6.0%
-10642.9%
Q2 24
10.1%
-5804.4%
Q1 24
4.3%
-10627.1%
EPS (diluted)
APT
APT
COCH
COCH
Q4 25
$0.06
$-0.27
Q3 25
$0.09
$-0.35
Q2 25
$0.12
$-0.32
Q1 25
$0.06
$-0.29
Q4 24
$0.07
$-0.40
Q3 24
$0.08
$-0.39
Q2 24
$0.15
$-0.29
Q1 24
$0.05
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APT
APT
COCH
COCH
Cash + ST InvestmentsLiquidity on hand
$17.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$62.5M
$-12.2M
Total Assets
$74.1M
$8.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APT
APT
COCH
COCH
Q4 25
$17.0M
Q3 25
$17.7M
Q2 25
$14.5M
Q1 25
$13.4M
Q4 24
$18.6M
Q3 24
$18.4M
Q2 24
$16.2M
Q1 24
$18.5M
Stockholders' Equity
APT
APT
COCH
COCH
Q4 25
$62.5M
$-12.2M
Q3 25
$62.5M
$-7.7M
Q2 25
$62.2M
$-29.9M
Q1 25
$61.7M
$-24.2M
Q4 24
$62.2M
$-18.8M
Q3 24
$62.1M
$-18.5M
Q2 24
$62.0M
$-12.4M
Q1 24
$61.6M
$-7.4M
Total Assets
APT
APT
COCH
COCH
Q4 25
$74.1M
$8.6M
Q3 25
$73.9M
$8.2M
Q2 25
$73.2M
$9.9M
Q1 25
$72.2M
$10.4M
Q4 24
$73.7M
$11.5M
Q3 24
$73.3M
$9.4M
Q2 24
$72.7M
$6.7M
Q1 24
$72.7M
$8.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APT
APT
COCH
COCH
Operating Cash FlowLast quarter
$318.0K
$-5.7M
Free Cash FlowOCF − Capex
$51.0K
$-5.9M
FCF MarginFCF / Revenue
0.4%
-7809.3%
Capex IntensityCapex / Revenue
1.9%
229.3%
Cash ConversionOCF / Net Profit
0.46×
TTM Free Cash FlowTrailing 4 quarters
$1.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APT
APT
COCH
COCH
Q4 25
$318.0K
$-5.7M
Q3 25
$3.9M
$-4.3M
Q2 25
$2.1M
$-4.5M
Q1 25
$-4.0M
$-3.7M
Q4 24
$2.4M
$-5.1M
Q3 24
$5.3M
$-2.6M
Q2 24
$-873.0K
$-4.6M
Q1 24
$-1.2M
$-5.6M
Free Cash Flow
APT
APT
COCH
COCH
Q4 25
$51.0K
$-5.9M
Q3 25
$3.8M
Q2 25
$1.9M
$-4.5M
Q1 25
$-4.1M
$-3.7M
Q4 24
$970.0K
Q3 24
$3.2M
$-3.8M
Q2 24
$-1.0M
Q1 24
$-1.3M
$-5.7M
FCF Margin
APT
APT
COCH
COCH
Q4 25
0.4%
-7809.3%
Q3 25
25.9%
Q2 25
11.7%
-5719.2%
Q1 25
-29.6%
-8110.9%
Q4 24
7.0%
Q3 24
22.3%
-6750.0%
Q2 24
-6.2%
Q1 24
-9.3%
-9657.6%
Capex Intensity
APT
APT
COCH
COCH
Q4 25
1.9%
229.3%
Q3 25
0.7%
0.0%
Q2 25
0.8%
1.3%
Q1 25
1.0%
13.0%
Q4 24
10.4%
Q3 24
15.1%
2066.1%
Q2 24
0.8%
Q1 24
0.6%
184.7%
Cash Conversion
APT
APT
COCH
COCH
Q4 25
0.46×
Q3 25
4.02×
Q2 25
1.68×
Q1 25
-6.46×
Q4 24
2.85×
Q3 24
6.18×
Q2 24
-0.53×
Q1 24
-2.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons